Publicacions en col·laboració amb investigadors/ores de Hospital Universitario Reina Sofia (17)

2018

  1. DNA methylation reprogramming of human cancer cells by expression of a plant 5-methylcytosine DNA glycosylase

    Epigenetics, Vol. 13, Núm. 1, pp. 95-107

2013

  1. Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL

    Bone Marrow Transplantation, Vol. 48, Núm. 3, pp. 396-402

2007

  1. Reticulocyte Maturation Parameters Are Reliable Early Predictors of Hematopoietic Engraftment after Allogeneic Stem Cell Transplantation

    Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 2, pp. 172-182

2006

  1. Cell cycle kinetic changes induced by interleukin-3 and interleukin-6 during ex vivo expansion of mobilized peripheral blood CD34 cells

    Haematologica, Vol. 91, Núm. 1, pp. 121-124

  2. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia

    Haematologica, Vol. 91, Núm. 3, pp. 340-347

2004

  1. Chemotherapy plus G-CSF mobilized peripheral blood stem cell harvests from acute myeloid leukaemia patients contain large amounts of polyclonal myeloid linnegCD11cpos dendritic precursor cells

    British Journal of Haematology, Vol. 124, Núm. 5, pp. 636-644

  2. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation

    British Journal of Haematology, Vol. 126, Núm. 5, pp. 697-703

  3. Pattern of expression of CXCR4 and adhesion molecules by human CD34 + cells from different sources: Role in homing efficiency in NOD/SCID mice

    Haematologica, Vol. 89, Núm. 9, pp. 1037-1045

2003

  1. BALB/C mice injected with LSTRA leukemic cell line are cured by in vivo treatment with IL-2 + GM-CSF

    Leukemia Research, Vol. 27, Núm. 4, pp. 351-357

  2. Utility of reticulocyte maturation parameters in the differential diagnosis of macrocytic anemias

    Clinical and Laboratory Haematology, Vol. 25, Núm. 5, pp. 283-288

2001

  1. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation

    Haematologica, Vol. 86, Núm. 1, pp. 24-29

  2. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice

    British Journal of Haematology, Vol. 114, Núm. 4, pp. 920-930

2000

  1. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: Increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse

    Blood, Vol. 95, Núm. 8, pp. 2659-2665

  2. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

    Haematologica, Vol. 85, Núm. 10, pp. 1072-1082

1999

  1. Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on)

    Bone Marrow Transplantation, Vol. 23, Núm. 12, pp. 1257-1260

  2. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft

    Bone Marrow Transplantation, Vol. 23, Núm. 5, pp. 443-450

1998

  1. Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome

    Bone Marrow Transplantation, Vol. 21, Núm. 4, pp. 375-382